Seeking Alpha

Cytokinetics (CYTK) says it's received notice from The Nasdaq Stock Market confirming that for...

Cytokinetics (CYTK) says it's received notice from The Nasdaq Stock Market confirming that for the last 10 consecutive business days, the closing bid price of its stock has been at $1.00 per share or greater, therby regained compliance with listing rules.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|